IDH1 and chondrosarcoma: Additionally, long-term treatment of chondrosarcoma cell lines with the IDH1 mutant inhibitor AGI-5198 does not alter the DNA methylation phenotype, suggesting that the epigenetic alterations might have become independent of the IDH1 mutation [61].